Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis

BACKGROUND/AIMS: Despite high mortality of alcohol-associated hepatitis, there has been limited advancement in treatment strategies. Defeat Alcoholic Steatohepatitis (DASH) is a multicenter, randomized, double-blind controlled trial whose primary objective was to evaluate the safety and efficacy of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Contemp Clin Trials
Autores principales: Dasarathy, Srinivasan, Mitchell, Mack C., Barton, Bruce, McClain, Craig J., Szabo, Gyongyi, Nagy, Laura E., Radaeva, Svetlana, McCullough, Arthur J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7494528/
https://ncbi.nlm.nih.gov/pubmed/32739495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2020.106094
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares